Form 4: Clover Health Director Vivek Garipalli Buys 877,567 Shares of Class A Common Stock

Vivek Garipalli, a director and 10% owner of Clover Health Investments, Corp., purchased 877,567 shares of Class A Common Stock at a weighted average price of $1.14 on June 17, 2024.

Summary

• On June 17, 2024, Vivek Garipalli, a director and 10% owner of Clover Health Investments, Corp., acquired 877,567 shares of Class A Common Stock.
• The shares were purchased at a weighted average price of $1.14.
• The prices for individual transactions ranged from $1.08 to $1.17.
• Following the transaction, Mr. Garipalli directly owns 877,567 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed as a positive sign, but the impact is moderate as it's a single transaction and doesn't provide comprehensive insight into the company's overall financial health.

Positives

• The purchase by a director and significant shareholder could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive signal, suggesting that those with the most knowledge of the company believe its stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.

Stakeholder Impact

• The purchase may positively influence shareholder sentiment.

Key Dates